Search

Your search keyword '"Weng, Jinsheng"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Weng, Jinsheng" Remove constraint Author: "Weng, Jinsheng"
134 results on '"Weng, Jinsheng"'

Search Results

5. Supplemental Figure S2 from Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma

6. Supplementary Tables from Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma

9. 296 Targeting B-cell malignancies with anti-ROR1 CAR T-cell therapy

21. Intraoperative Chemotherapy with a Novel Regimen Improved the Therapeutic Outcomes of Colorectal Cancer

22. Circular RNA hsa_circ_0001829 promotes gastric cancer progression through miR-155-5p/SMAD2 axis.

23. Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas

25. Identification of surrogate prognostic biomarkers for allergic asthma in nasal epithelial brushing samples by WGCNA

26. MicroRNA‐21 increases the expression level of occludin through regulating ROCK1 in prevention of intestinal barrier dysfunction

28. Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma

29. Abstract 2566: A TCL1-specific T-cell receptor redirects T cells against B-cell lymphomas and non-hematological tumors

33. Targeting of Toll-like receptors inhibits CD4+ regulatory T cell function and activates lymphocytes in human PBMCs

34. IL-15 enhances the antitumor effect of human antigen-specific CD8+T cells by cellular senescence delay

35. Targeting B-cell malignancies through human B-cell receptor specific CD4+T cells

36. Lgr4 in Ocular Development and Glaucoma

37. CXCR5+CD8+T cells are a distinct functional subset with an antitumor activity

40. PR1 Is Cross-Presented By Multiple Myeloma Cells in Patients and Renders Multiple Myeloma Susceptible to PR1-CTL and Anti-PR1/HLA-A2 Antibody

45. Multiple Myeloma Cross-Presents Neutrophil Elastase and Proteinase 3 and Becomes Susceptible to PR1-Targeting Immunotherapy

46. Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8+ T Cells for Cancer Immunotherapy

50. Regulation of bone formation and remodeling by G-protein-coupled receptor 48

Catalog

Books, media, physical & digital resources